AUTHOR=Laugisch Oliver , Ruppert-Jungck Marina C. , Auschill Thorsten M. , Eick Sigrun , Sculean Anton , Heumann Christian , Timmermann Lars , Pedrosa David J. , Eggers Carsten , Arweiler Nicole B. 

TITLE=Glucose-6-Phosphatase-Dehydrogenase activity as modulative association between Parkinson’s disease and periodontitis

JOURNAL=Frontiers in Cellular and Infection Microbiology

VOLUME=14

YEAR=2024

URL=https://www.frontiersin.org/journals/cellular-and-infection-microbiology/articles/10.3389/fcimb.2024.1298546

DOI=10.3389/fcimb.2024.1298546

ISSN=2235-2988

ABSTRACT=<p>The association between periodontitis (PD) and Parkinson’s disease (PK) is discussed due to the inflammatory component of neurodegenerative processes. PK severity and affected areas were determined using the following neuropsychological tests: Unified Parkinson’s Disease Rating Score (UPDRS) and Hoehn and Yahr; non-motoric symptoms by Non-Motor Symptoms Scale (NMSS), and cognitive involvement by Mini-Mental State Examination (MMSE). Neuroinflammation and the resulting Glucose-6-Phosphatase-Dehydrogenase (G6PD) dysfunction are part of the pathophysiology of PK. This study aimed to evaluate these associations in periodontal inflammation. Clinical data and saliva-, serum-, and RNA-biobank samples of 50 well-characterized diametric patients with PK and five age- and sex-matched neurologically healthy participants were analyzed for G6PD function, periodontal pathogens (<italic>Aggregatibacter actinomycetemcomitans, Porphyromonas gingivalis, Tannerella forsythia, Treponema denticola, Prevotella intermedia, Campylobacter rectus, Fusobacterium nucleatum</italic>, and <italic>Filifactor alocis)</italic>, monocyte chemoattractant protein (MCP) 1, and interleukin (IL) 1-beta. Regression analysis was used to identify associations between clinical and behavioral data, and t-tests were used to compare health and disease. Compared with PK, no pathogens and lower inflammatory markers (p &lt; 0.001) were detectible in healthy saliva and serum, PK-severity/UPDRS interrelated with the occurrence of <italic>Prevotella intermedia</italic> in serum as well as IL1-beta levels in serum and saliva (p = 0.006, 0.019, 0.034), Hoehn and Yahr correlated with <italic>Porphyromonas gingivalis</italic>, <italic>Prevotella intermedia</italic>, RNA IL1-beta regulation, serum, and saliva IL1-beta levels, with p-values of 0.038, 0.011, 0.008, &lt;0.001, and 0.010, while MMSE was associated with <italic>Aggregatibacter actinomycetemcomitans</italic>, <italic>Fusobacterium nucleatum</italic>, serum MCP 1 levels, RNA IL1-beta regulation and G6PD serum activity (p = 0.036, 0.003, 0.045, &lt;0.001, and 0.021). Cognitive and motor skills seem to be important as representative tests are associated with periodontal pathogens and oral/general inflammation, wherein G6PD-saliva dysfunction might be involved.</p><sec><title>Clinical trial registration</title><p><uri xlink:href="https://www.bfarm.de/DE/Das-BfArM/Aufgaben/Deutsches-Register-Klinischer-Studien/_node.html" xmlns:xlink="http://www.w3.org/1999/xlink">https://www.bfarm.de/DE/Das-BfArM/Aufgaben/Deutsches-Register-Klinischer-Studien/_node.html</uri>, identifier DRKS00005388.</p></sec>